Lucid Diagnostics (LUCD) EPS (Diluted) (2022 - 2026)

Lucid Diagnostics (LUCD) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Abbott Laboratories 184.32 Bn 177.02 Bn 6.27 Bn 0.62
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn 1.93
3 Medtronic 108.88 Bn 99.66 Bn 6.41 Bn 0.98
4 Boston Scientific 68.65 Bn 67.20 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 47.43 Bn 43.76 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.48 Bn 26.19 Bn 1.98 Bn 0.90
7 Dexcom 28.45 Bn 27.33 Bn 750.30 Mn 0.51
8 Smith & Nephew 26.98 Bn 26.40 Bn - -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn 0.18
10 Lucid Diagnostics 131.49 Mn 103.62 Mn -325,000.00 -0.22

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.22
Dec 31, 2025 -0.15
Sep 30, 2025 -0.10
Jun 30, 2025 -0.08
Mar 31, 2025 -0.52
Dec 31, 2024 -0.23
Sep 30, 2024 -0.25
Jun 30, 2024 -0.23
Mar 31, 2024 -0.40
Dec 31, 2023 -0.26
Sep 30, 2023 -0.34
Jun 30, 2023 -0.27
Mar 31, 2023 -0.40
Dec 31, 2022 -0.41
Sep 30, 2022 -0.39
Jun 30, 2022 -0.41